Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors

被引:85
作者
Choi, Ji Won [1 ,2 ]
Jang, Bo Ko [1 ,3 ]
Cho, Nam-chul [1 ]
Park, Jong-Hyun [1 ]
Yeon, Seul Ki [1 ]
Ju, Eun Ji [1 ]
Lee, Yong Sup
Han, Gyoonhee [2 ]
Pae, Ae Nim [1 ,4 ]
Kim, Dong Jin [1 ]
Park, Ki Duk [1 ,4 ]
机构
[1] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul 136791, South Korea
[2] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea
[3] Kyung Hee Univ, Coll Pharm, Dept Pharm, Seoul 130701, South Korea
[4] Univ Sci & Technol, Dept Biol Chem, Taejon 305350, South Korea
关键词
alpha; beta-Unsaturated carbonyl derivatives; Chalcone; Monoamine oxidase; MAO-B inhibitor; Reversible inhibitor; PARKINSONS-DISEASE; CHALCONE DERIVATIVES; B INHIBITORS; AMINO-ACID; SUBSTRATE; UPDATE; MODELS; POTENT; AGENTS;
D O I
10.1016/j.bmc.2015.08.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have synthesized three categories of alpha,beta-unsaturated carbonyl derivatives and evaluated their MAO-A and MAO-B inhibitory activities. Among them, compound 10b including alpha, beta-unsaturated ketone group showed the most potent and selective MAO-B inhibitory activity (IC50 human MAO-B 16 nM, >6000-fold selective vs MAO-A) and compound 10b exhibited good reversibility compared with selegiline, a well-known irreversible MAO-B inhibitor. However, both a, b-unsaturated amide and ester derivatives exhibited weaker MAO-B inhibition potencies. The docking studies provided insights into the possible binding modes and the key interaction sites of the synthesized MAO-B inhibitors. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6486 / 6496
页数:11
相关论文
共 30 条
[1]   Novel monoamine oxidase inhibitors: a patent review (2012-2014) [J].
Carradori, Simone ;
Petzer, Jacobus P. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (01) :91-110
[2]   Chalcones: A Valid Scaffold for Monoamine Oxidases Inhibitors [J].
Chimenti, Franco ;
Fioravanti, Rossella ;
Bolasco, Adriana ;
Chimenti, Paola ;
Secci, Daniela ;
Rossi, Francesca ;
Yanez, Matilde ;
Orallo, Francisco ;
Ortuso, Francesco ;
Alcaro, Stefano .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) :2818-2824
[3]   Homoisoflavonoids: Natural Scaffolds with Potent and Selective Monoamine Oxidase-B Inhibition Properties [J].
Desideri, Nicoletta ;
Bolasco, Adriana ;
Fioravanti, Rossella ;
Monaco, Luca Proietti ;
Orallo, Francisco ;
Yanez, Matilde ;
Ortuso, Francesco ;
Acaro, Stefano .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) :2155-2164
[4]   Natural and synthetic 2′-hydroxy-chalcones and aurones: Synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity [J].
Detsi, Anastasia ;
Majdalani, Maya ;
Kontogiorgis, Christos A. ;
Hadjipavlou-Litina, Dimitra ;
Kefalas, Panagiotis .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (23) :8073-8085
[5]  
Dimmock JR, 1999, CURR MED CHEM, V6, P1125
[6]   Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease [J].
Duty, Susan ;
Jenner, Peter .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) :1357-1391
[7]   Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release [J].
Finberg, John P. M. .
PHARMACOLOGY & THERAPEUTICS, 2014, 143 (02) :133-152
[8]   Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid [J].
Geha, RM ;
Rebrin, I ;
Chen, K ;
Shih, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :9877-9882
[9]   Chalcones: An update on cytotoxic and chemoprotective properties [J].
Go, ML ;
Wu, X ;
Liu, XL .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (04) :483-499
[10]   CHARACTERIZATION OF WILD-TYPE AND MUTANT FORMS OF HUMAN MONOAMINE OXIDASE-A AND OXIDASE-B EXPRESSED IN A MAMMALIAN-CELL LINE [J].
GOTTOWIK, J ;
CESURA, AM ;
MALHERBE, P ;
LANG, G ;
DAPRADA, M .
FEBS LETTERS, 1993, 317 (1-2) :152-156